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Summary The hypothesis that metastases arise from pre-existing metastatic sub-populations of cancer cells
with heritable metastasis-related characteristics, was tested by comparing the metastatic behaviour of cancer
cells derived from pulmonary metastases with those from corresponding primary tumours, after implanting
them subcutaneously in mice. In the case of KHT osteosarcomas and B16 melanomas, injected minces of
metastases gave rise to more pulmonary metastases than cells derived from minces of the primary cancers
generating them. However, in the case of 3LL and T241 cancers, the primary tumour minces gave rise to
more pulmonary metastases than those derived from minced metastases. It is therefore concluded that the
subpopulation hypothesis cannot be accepted as a general rule. When fragments of solid tumours were
implanted into animals, no differences were detected between the metastatic behaviour of implants taken
randomly from pulmonary metastases and the volume/age matched primary tumours generating them. These
experiments thus provide no support for the hypothesis that metastases arise exclusively or predominantly
from pre-existing metastatic subpopulations of cancer cells. Finally, implants of matched fragments from 3LL
tumours of different volume and age, essentially produced no statistically significant differences in numbers of
metastases. These observations do not therefore support the concept of a progressive evolution of
subpopulations of cancer cells with heritable metastatic phenotypes during tumour growth.
It has been suggested that metastases arise
exclusively or predominantly from pre-existing
metastatic subpopulations of cancer cells within
primary tumours, with the implication that the so-
called "metastatic phenotype" is heritable. In this
paper we report on some simple tests made of this
interesting hypothesis.
Materials and methods
Overall design ofexperiments
"Source" mice were given either s.c. tumour mince
injections or implants of solid tumour cylinders into
their flanks. Tumours developed in these sites and
metastasized into the lungs. Our basic experiment
was to assay both the s.c. tumours and the
metastases developing from them for (pulmonary)
metastatic capability by injecting or implanting
aliquots subcutaneously into the flanks of animals
of"primary" or "secondary" groups, respectively.
Animals and tumours
The KHT osteosarcoma (Kallman et al., 1967) is
carried in 6-8 week C3Hf/HeHa male mice; Lewis
lung (3LL) and T241 carcinomas and the B16 (wild
type) melanoma are carried in 6-8 week C57B1/6J
male mice. Tumours were passaged by s.c. injections
of tumour mince into the flank.
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Tumour mince experiments
Subcutaneous tumours and their pulmonary
metastases were removed from "source" mice,
minced with fine scissors, suspended in Hanks'
balanced saline and 0.1ml (18ga. needle) injected
s.c. into the flanks of mice of either "primary" or
"secondary" groups respectively. Injections
contained - 105 cancer cells, of which - 30% were
viable on the basis of trypan blue exclusion. The
size of the developing s.c. tumours was monitored
by caliper measurements and, after killing animals
by cervical dislocation, the volumes of the excised
tumours were determined by fluid displacement.
The lungs were removed and the metastases
counted under a dissecting microscope ( x 8 magn.).
All lungs removed from animals in the "primary"
and "secondary" groups were monitored by
examinations of stained sections throughout the
experiments.
Tumourfragment experiments
In an attempt to equalize the volumes of the s.c.
tumours developing in the experimental groups,
matched weights of s.c. and pulmonary tumours
from the "source" mice were implanted into the
"primary" and "secondary" groups respectively. To
weight-match tumours, spherical pulmonary
metastases of known diameters and primary tumour
cylinders of varying lengths (obtained with 2mm
diameter cannula and trocar) were weighed for each
tumour type. In the final experiments, the length of
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s.c. tumour cylinders implanted into "primary"
animals was determined by the size of pulmonary
metastases implanted into "secondary" animals. In
the case of KHT tumours, a mean of 1.0+0.2
(S.E.)mg of metastases were implanted; in the 3LL
tumours, 4.0+0.3mg, and in the T241 tumours, 3.1
+0.3mg. Fragments of lung from non-tumour-
bearing animals were implanted into animals of the
"primary" group together with tumour cylinders.
In another series of experiments made exclusively
with 3LL tumours, an attempt was made to
determine the effect of growth status of whole
tumours on the metastatic capacity of fragments
taken from them. This was accomplished by using 2
(1 x 2mm) tumour cylinders taken from "donor"
cancers (of measured volumes) aged 5, 7, 9, 15, 19
and 21 days implanted s.c. into fresh recipients. In
the 21 day "donor" cancers, tumour cylinders were
taken from both cortical and juxtanecrotic regions
and implanted into C or J sub-groups respectively.
The mean cancer cell densities and mitotic indices
were determined on a 5pm thick, haemotoxylin and
eosin-stained sections of representative cylinders.
The recipients were killed 15 or 21 days after
receiving implants, and their pulmonary metastases
counted.
Analyses ofdata
The numbers of pulmonary metastases in the
"primary", "secondary" and "source" experimental
groups were compared by means of Student's t-test
and the non-parametric Wilcoxon-Mann-Whitney
test. Some experiments were terminated at a set
time after injecting animals, and others when their
s.c. tumours reached a set size as monitored by
caliper measurements. Inspection of the results
indicated that the average numbers of pulmonary
metastases increased with some function of
development-time and volume of the s.c. tumours
generating them. In addition, the size of tumours
developing within set times must also bear some
relationship to the numbers of cancer cells injected.
Although the doses of cancer cells injected s.c. into
mice in the "source" and "primary" groups were
reproducible as assessed by tumour growth-rate, the
numbers present in the lung mince of individual
"source" mice were variable as assessed by the
volumes of tumours developing in recipient mice
of the "secondary" groups. Therefore, in addition to
comparing numbers of pulmonary metastases in all
animals in the three experimental groups, data were
also selected on the basis of development-time or
volume of the s.c. tumours as indicated in Tables 1
and 4, in an attempt to minimize differences
between the groups with respect to both of these
variables.
Results
Minced tumour recipients
The major results are summarized in Table I and
their statistical analyses shown in Table II.
KHT tumours In both the selected and unselected
series, animals in the "secondary" group, which
received subcutaneous injections (s.c.i.) of minced
lung metastases, developed significantly more
pulmonary metastases than those in the "primary"
group which received s.c.i. of minced subcutaneous
tumours. The selected groups had a lower degree of
significance in the t-tests compared with the total
data (i.e., P=0.03 c.f. P=0.002). Over a similar
period of time, no statistically significant differences
were detected in the number of metastases
developing in the "source" and "primary" groups.
3LL tumours Use of unselected data revealed no
differences between the numbers of pulmonary
metastases developing in the "primary" and "second-
ary" groups. In contrast, examination of the selected
data revealed significantly more pulmonary
metastases in both the "primary" and "source" than
"secondary" groups.
1241 tumour The selected data revealed
significantly more pulmonary metastases in the
"primary" and "source" than in the "secondary"
groups of mice. Examination of the total data
revealed marginally significant differences between
the "primary" and "secondary" groups, but
significantly more pulmonary metastases in the
"source" than in the "secondary" groups of animals.
B16 melanoma The unselected data revealed
significantly more pulmonary metastases in the
"secondary" than "primary" and "source" groups.
However, this occurred against a variable metastatic
background as evidenced by the presence of
significantly more metastases in the "source" than
in the "primary" groups. In addition, the injections
in the "secondary" animals required almost twice the
time to achieve tumour volumes comparable to the
other 2 groups. Comparisons made between groups
selected on the basis of 21-30 days elapsed-time
(where both mean s.c. tumour volume and elapsed-
time were not different) failed to reveal significant
differences between the numbers of pulmonary
metastases in the 3 groups of animals.
Tumourfragment recipients
The results are summarized in Table III and analyzed
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Table I Numbers of lung metastases generated from s.c. injection sites in "source" animals, or following injection of
cancer cell suspensions from either s.c. tumours from "source" animals ("Primary" group) or their pulmonary metastases
("Secondary" group).
"Source" (S) group "Primary" (1°) group "Secondary" (2°) group
Lung Lung Lung
metastases metastases metastases
Mean+s.e. S.C. Tumour Mean+s.e. S.C. Tumour Mean+s.e. S.C. Tumour
(No. obs.) Volume (ml) Days (No. obs.) Volume (ml) Days (No. obs.) Volume (ml) Days
Thmour Median (Range) Mean+s.e. Mean+s.e.Median (Range)Mean +s.e. Mean+s.e.Median (Range)Mean+s.e. Mean+s.e.
KHT:
6.0+0.7(42)
5(0-19)
6.8+0.8(29)
5(1-19)
13.2+2.4(20)
10(2-35)
21.0+3.1(10)
17.5(9-35)
15.6+ 1.4(20)
15(7-34)
15.6+ 1.4(19)
14(7-34)
4.5+0.5(39)
4(0-15)
2.3+0.7(15)
2(0-10)
4.5+0.3
3.8+0.3
2.4+0.2
3.2+0.2
1.4+0.1
1.3+0.1
2.9+0.2
2.9+0.4
18 +0.5
20+0.3
13 +0.3
14+0
21 +0.2
21+0.2
21+0.5
25+0.4
7.3 +0.9(44)
6(0-23)
6.7+ 1.4(18)
7(0-19)
23.3 +5.3(19)
12(5-94)
20.3 +5.5(17)
11(5-94)
16.4+2.6(19)
16(0-43)
17.9+2.6
16(4-43)
2.3+0.5(35)
1(0-8)
2.3 +0.7(18)
1(0-8)
5.0+0.3
4.1 +0.3
2.8 +0.3
2.9+0.3
1.0+0.1
1.1 +0.1
2.8+0.2
3.2+0.3
16.5+0.5
19.5+0.5
15+0.6
15.1 +0.6
17+0.3
17+0.2
22+1.4
28+1.9
14.1 + 1.9(44)
10(0-51)
13.3 +2.0(31)
10(044)
17.4+4.3(18)
7(5-53)
8.0+2.5(13)
6(3-37)
10.5+ 1.7(20)
9(3-28)
10.9+2.0(17)
8(3-28)
10.6+2.1(29)
7(0-40)
5.3+ 1.6(11)
4(0-18)
4.4+0.4
3.9+0.4
3.7+0.4
3.2+0.4
1.6+0.2
1.3+0.2
2.6+0.1
2.5+0.2
23 + 1.0
20.5+0.5
20+2.0
15+ 1.2
18 +0.3
18+0.4
38+2.1
27+ 1.1
The volumes of the s.c. tumours and the elapsed time from s.c. injection to death are shown for all animals, and for
groups selected on the basis of volume and time as indicated.
KHT tumours In the unselected groups, s.c.
implants derived from metastases gave rise to
significantly more pulmonary metastases than
implants derived from s.c. "primary" and "source"
cancers. However, when the groups were selected on
the basis of volume and elapsed-time, the differences
between the "primary" and "secondary" groups
were not statistically significant. Although the mean
and median number of pulmonary metastases in the
"secondary" group are approximately 3- and 5-fold
that in the "primary" group, the high standard
errors and wide ranges prevent a significant
difference.
3LL tumours In the unselected groups, significantly
more pulmonary metastases also occur in the
"secondary" than in the "source" and "primary"
groups. However, the unselected "source" and
"primary" groups are also significantly different
from each other. When the selection criteria are
applied, the numbers of metastases in the "primary"
and "secondary" groups are not significantly
different.
T241 tumours Both in the selected and unselected
groups, the numbers of metastases in the various
experimental groups were not significantly different.
Growth status of tumour implant material
The measured volumes of 3LL tumours implanted
s.c. in the flanks of C57B1/6J mice are shown in
Figure 1. After a period of 15 days in "logarithmic"
growth, tumour volume remained constant up until
21 days. Apart from those animals killed at 9 days,
the progressive increase in tumour volume was
associated with an increase in metastasis number.
All
Results
Selected
groups
Lewis
Lung
(3LL)
All
Results
Selected
Groups
T241:
All
Results
Selected
Groups
B16:
All
Results
Selected
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Table II Statistical analysis by means of Student's t-test and Wilcoxon-Mann-Whitney (W.M.W.)
test, of the numbers ofpulmonary metastases developing in the animals described in Table 1.
Source vs 10 10 vs 20 Source vs 20
t-test W.M.W. t-test W.M. W. t-test W.M. W.
Tumour Data P P P P P P
KHT All 0.25 >0.2 0.002 <0.01 0.0002 <0.01
10<20 s<2°
Selected 0.96 >0.2 0.03 0.05 > P>0.01 0.005 0.05>p>0.01
1<2" s<20
3LL All 0.09 0.2>P>0.1 0.4 0.2>P>0.1 0.4 >0.2
Selected 0.93 >0.2 0.07 <0.01 0.003 <0.01
1°>2 s>20
T241 All 0.8 >0.2 0.06 0.1 >P>0.05 0.03 <0.01
s>20
Selected 0.4 >0.2 0.04 0.05>P>0.0l 0.06 0.05>P>0.0l
10>2° s>20
B16 All 0.003 <0.01 0.00006 <0.01 0.002 0.05>P>0.01
s> 10 1<2' s<2
Selected 0.99 >0.2 0.06 0.1 > P>0.05 0.07 0.2> P>0.1
Statistically significant differences between
groups are indicated.
the "source" (S), "primary" (1) and "secondary" (20)
Table III Numbers of lung metastases generated from s.c. implantation sites in "source" animals, or following
implantation of matched tumour fragments from either s.c. tumours from "source" animals ("primary" group) or their
pulmonary metastases ("secondary" group).
"Source" (S) group "Primary" (10) group "Secondary" (2 ) group
Lung Lung Lung
Metastases Metastases Metastases
Mean+s.e. S.C. Tumour Mean+s.e. S.C. Tumour Mean+s.e. S.C. Tumour
(No. obs.) Volume (ml) Days (No. obs.) Volume (ml) Days (No. obs.) Volume (ml) Days
Tmour Median (Range) Mean+s.e. Mean+s.e.Median (Range) Mean+s.e. Mean+s.e. Median Range Mean+s.e. Mean+s.e.
KHT:
All
Results
Selected
Groups
8.2+ 1.6(19)
8(0-27)
9.2+2.7(10)
8(0-27)
3LL:
All 23.2+4.9(19)
Results 19(3-96)
Selected 19.7+3.1(9)
Groups 20(8-36)
T241:
All 15.8+3.1(15)
Groups 17(0-43)
Selected 16.6+3.2(14)
Groups 18(0-43)
11.9+0.9
9.9+0.9
6.2+0.6
5.9+0.5
5.4+0.3
5.3+0.3
25+ 1.1
26+ 1.6
23+0.6
24+0.5
36+0.8
36+0.7
6.2+2.1(16)
2(0-28)
8.3+3.2(10)
3(0-28)
40.0+5.5(33)
32(2-127)
42.7+6.4(27)
38(2-127)
17.0+ 3.9(17)
12(1-63)
17.1 + 3.9(17)
12(1-63)
10.1+0.8
10.7+ 1.1
5.7+0.2
5.6+0.2
6.0+0.3
6.0+0.3
24+0.8
25+0.7
23+0.6
24+0.6
36+ 1.4
36+ 1.4
22.4+5.8(19)
12(0-81)
22.5+9.2(10)
14(0-81)
64.9+8.4(35)
55(6-257)
59.1 +6.9(31)
55(6-191)
8.5+0.6
8.3+0.8
5.2+0.2
5.3 +0.2
34.9± 10.2(17) 5.0+0.3
15(1-137)
32.2± 11.0(13) 5.2+0.4
15(1-137)
Volumes of s.c. tumours and the elapsed time from implantation to death are shown for all animals, and for groups
selected on the basis of volume and time as indicated.
32+ 1.9
27+ 1.1
26+0.5
25+0.5
43+2.7
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Table IV Statistical analyses made on numbers of pulmonary metastases in the different groups by
means of Student's t-test and the Wilcoxon-Mann-Whitney (W.M.W.) test.
"Source" vs 1P 1P vs 2° Source vs 20
t-test W.M.W. t-test W.M. W. t-test W.M.W.
Tumour Data P P P P P P
KHT All 0.45 0.2>P>O.l 0.02 0.05>P>0.01 0.02 0.2>P>0.1
1P<2° s<2°
Selected 0.83 >0.2 0.16 >0.2 0.18 >0.2
3LL All 0.05 0.05>P>0.01 0.02 0.05>P>0.01 0.001 <0.01
s< 1 V<2 s<2°
Selected 0.05 0.1 > P>0.05 0.09 0.1 >P>0.05 0.005 <0.01
s<2°
T241 All 0.8 >0.2 0.11 >0.2 0.10 >0.2
Selected 0.9 >0.2 0.16 >0.2 0.17 >0.2
10
1.0 - E
0
E
3
'5
0.1-
0.03
a
5 7 9 15 1921
Days
Figure 1 The volumes of;
times after s.c. implantation.
3LL tumours at specified
As shown in Table V, the relative cancer cell
densities counted in sections of these tumours,
approximately doubled in the 15-, 19- and 21-day
specimens compared with those taken at 5, 7, and 9
days. The mitotic indices were not substantially
different over this time period, although in the 21-
day tumours they were twice as high in the
juxtanecrotic central regions than in the cortical
regions (P=0.003). The numbers of pulmonary
metastases developing by 15 and 21 days in
recipients of these tumours are also shown in Table
V. The Wilcoxon-Mann-Whitney test shows that
significantly more metastases were present 15 days
after implantation in the recipients of 7-day tumour
fragments than in those receiving 19-day tumour-
fragments (0.05>P>0.01) and that by 21 days more
metastases developed in the 19-day than 5-day
recipients (0.05>P>0.01). Apart from these
differences, neither the mean nor the median
numbers of metastases developing after 15 and 21
days in all groups of recipients were significantly
different.
Discussion
Although it was suggested by Leighton in 1965 that
metastases might arise from special genetically-
determined subpopulations in primary cancers,
serious attempts to approach the problem
experimentally have only been made comparatively
recently by Fidler and his colleagues (Fidler &
Kripke, 1977) and subsequently by others.
Various considerations have led to the suggestion
that cancer cells in metastases have different
functional spectra from those in the primary cancers
from which they arose. However, the validity of a
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number of these observations is dubious (Weiss,
1980a) and is complicated by environmental factors
modifying cells (Weiss & Harlos, 1979) which may
account for differences occurring after metastases
have developed, as distinct from pre-existing
differences in cancer cells causing metastases.
The issue of pre-existing metastatic
subpopulations is often confused with the non-
controversial issues of the heterogeneity of cancer
cell populations and the establishment in vitro of
sublines of cancer cells with different metastasis-
related properties. Cancer cell heterogeneity or
pleiomorphism has long been recognized as a
diagnostic feature by histopathologists, and has been
characterized in terms of many different
experimental parameters by investigators in many
different disciplines. Following the work of Fidler
and his colleagues (Fidler, 1973; 1978; Kripke et al.,
1978) it has also been unequivocally demonstrated,
albeit with a small number of different tumours,
that in vitro cloning procedures can result in
somewhat unstable (Kerbel, 1979) cell lines. When
these cell lines are injected into mice, particularly
by the intravenous route, they give rise to either
more or less pulmonary colonies than wild-type
populations from which they were derived.
However, in the present context, the major issue is
not whether cancer cell-lines selected and/or
maintained in vitro exhibit different metastasis-
related properties, but rather whether pre-existing
metastatic sub-populations of cancer cells play a
key role in the genesis of "natural" metastasis
Table V Effects of growth status of donor 3LL tumours on the growth and metastatic behaviour of s.c. implants in fresh
recipients
Donor material Recipient
Metastases numbers Metastases numbers
Age of Tumour Mean cell 1P tumour
transplant vol (ml) Median density Mitotic Age Vol (ml) Median
(days) (No. obs.) Mean±s.e. (Range) ±s.e./Field Index+s.e. (Days) ±s.e. Mean+s.e. (Range)
5 0.04+0.01 0.7+0.26 0.5 72.4+1.7 1.53+0.22 15 2.46+0.38 3.9+0.89 3.5
(10) (0-2) (47) (10) (0-10)
21 2.83+0.34 14.8+4.83 13
(10) (0-54)
7 0.24+0.06 3.5+0.82 3 55.3+2.2 1.62+0.24 15 2.22+0.32 6.5+1.75 6.5
(10) (1-10) (48) (10) (1-20)
21 3.11 +0.54 15.33+5,26 9
(9) (1-49)
9 0.48+0.06 0.4+0.31 0 69.9+3.7 1.36+0.21 15 2.53+0.27 4.7+1.63 3
(10) (0-3) (46) (10) (0-18)
21 5.34+0.54 29.8+7.51 23
(10) (5-87)
15 3.8+0.23 12.8+3.36 8.5 121.4+3.5 1.56+0.17 15 2.05+0.28 2.7+0.78 2
(10) (1-32) (50) (10) (0-8)
21 4.46+0.63 27.88+5.04 23.5
(8) (9-45)
19 5.7+0.40 24.9+4.22 23 125.3+2.2 1.24+0.11 15 2.72+0.27 2.11 +0.48 2
(10) (7-45) (47) (9) (0-4)
21 4.61 +0.53 29.3+9.1 24
(8) (8-90)
21 5.6+0.3 25.5+4.53 24.5 136.9+2.5 0.98+0.14 15 2.36+0.25 4.4+0.98 3
(C) (10) (6-45) (49) (10) (0-9)
21 4.12+0.80 12.67+3.84 11
(6) (2-26)
21 115.5+4.2 1.97+0.29 15 2.00+0.28 6.3+2.2 4
(J) (49) (10) (0-21)
21 3.38+0.78 18.63+6.28 12.5
(8) (5-60)
Mean cancer cell densities were determined on 0.019mm2 microscopic fields on 5,im sections; mitotic indices (M.I.) are
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within the time-frame of the life of individual hosts.
One example of many illustrating this difference is
provided by N-methyl-N-nitrosourea-induced
mammary carcinomas in rats, which do not
spontaneously metastasize. However, metastasizing
tumours have been derived from these cancers by in
vitro and selection techniques (Williams et al., 1982).
If these metastasizing variants pre-exist within the
tumours, we are justified in asking why the
adenocarcinomas are not spontaneously metastatic
within the time constraints. Mechanistic differences
between B16 cell lines in vitro in relation to
spontaneous metastasis have been identified (Weiss
et al., 1982).
In a review (Weiss, 1980a), it was suggested that a
critical test of the "pre-existing metastatic
subpopulation" hypothesis would be simple
bioassay of the differential metastatic potential of
cancer cells taken from primary cancers and their
metastases in the same host. If the hypothesis is
correct, it might reasonably be expected that on
inoculation into similar sites in animals of the same
inbred strain, cells derived from pulmonary
metastases should give rise to more metastases than
cells derived from the primary cancer generating
them.
Experiments of this type were in fact described by
Giavazzi et al. (1980) in which the metastasizing
capacities of cancer cells from spontaneous
metastases were compared with those from the
transplanted murine tumours from which they
arose. They noted that in general, cancer cells from
a spontaneous metastasis did not show greater
metastatic capacity than those from primary
tumours. The authors were thus unable to support
the hypothesis that metastasis are derived from
selected variant cells with increased metastatic
potential which pre-exist within primary tumours.
Some index of the stability in metastatic potential
of the different tumour groups comes from
comparison of the "source" and "primary" groups
(Table II). Apart from the unselected B16 data all of
the tumour systems are stable with respect to
metastasis within the time-frame.
The relationships between primary tumour
volume, age and growth-rate on the one hand, and
metastasis on the other are extremely complex
(Wood et al., 1954; Weiss, 1967; Steel, 1977).
However, given similar tumour types, it appears in
general that the bigger the primary cancers and/or
the more rapidly they grow, the greater the degree
ofmetastases (Figure 1; Table V). In addition, in vivo
primary tumour size within given time limits
depends upon the numbers of cancer cells injected
into the primary site. In the present work, it proved
impossible to accurately count the numbers of
viable cancer cells at the time of injection,
particularly when they were obtained from the
lungs of the "source" animals. This difficulty, which
is avoided when cells are injected directly from
cultures, is often reflected in wide ranges in numbers
of metastases, mean tumour volumes and times
between injection and death in animals of the
unselected "primary" and "secondary" groups
(Tables I-III). We therefore tend to have less
confidence in differences between the unselected
groups than between groups selected in such a
manner as to minimize differences between
subcutaneous tumour volumes and elapsed-times,
even though the selection procedures reduce the
numbers of animals in the individual groups.
The data given in Table 1 shows that in the case
of KHT and B16 tumours, when the selected
"primary" and "secondary" groups of animals are
compared, cancer cells from minces of the latter
gave rise to significantly more metastases than the
former. However, in the case of the 3LL and T241
tumours, cells obtained from minced "primary"
lesions gave rise to significantly more metastases
than those derived from pulmonary metastases.
Thus, if the evidence supporting the concept
that metastases arise from pre-existing metastatic
subpopulations in KHT and B16 tumours is
accepted, we must also accept the evidence based
on the same criteria that the 3LL and T241 do not.
The subpopulation hypothesis cannot therefore be
accepted as a general case. Finally, the experiments
made with the 3LL and T241 tumours would
suggest that once established, metastases from these
tumours would be less likely to metastasize to
additional sites within their hosts than cells from
the primary cancers generating them; this
phenomenon could contribute to metastatic
inefficiency (Weiss, 1982).
In describing the preparation of tumour minces
for injection, we noted that only - 30% of the
cancer cells obtained were viable. This raises the
possibility that our results were influenced by
preparative selection artifacts; whatever technique is
used to isolate cells from solid tumours, this
possibility remains. We therefore implanted
matched undissociated fragments of solid tumours
as a check on the experiments utilizing tumour
minces. Unfortunately, it was not possible to
implant reproducible fragments of B16 tumours,
because of the ease with which they dissociated on
handling.
The results with tumour fragments show that in
the case of animals bearing subcutaneous tumours
which were matched on the basis of volume and
time after implantation, no statistically significant
differences were observed in numbers of metastases
in the "primary" and "secondary" groups. Thus,
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heritable metastatic phenotype or that metastases
arise exclusively from pre-existing metastatic
subpopulations. The fact that significant differences
were observed with unselected data indicates a
source of potential error in the interpretation of
these types of experimental data, when metastases
are enumerated without reference to the volume
and age of the "primary" lesions generating them.
The results given in Table V show progressive
increases in both "primary" 3LL tumour volume
and numbers of pulmonary metastases with time. A
solitary exception was seen after 9 days, when the
numbers of metastases were disproportionately low.
On the one hand, this general increase in
metastatic number with primary tumour volume
and age would be expected if metastasis were a
stochastic (random) process in terms of cancer cells.
On the other hand, the increase could also have
been due to the presence of increasing numbers of
metastatic "mutants" or subpopulations within the
implants, as their constituent cancer cell
populations became larger in line with the concept
of tumour progression (Foulds, 1969). In order to
discriminate between these two hypotheses,
similarly sized fragments from "donor" tumours of
different volume and age were implanted into fresh
recipients. If the older, larger tumours contained
more cells of a metastatic phenotype, then it would
be expected that more metastases would arise from
implants of similar volume taken from them than
from younger, smaller tumours. In contrast, if
metastasis from these "donor" tumours were a
random process, then no differences would be
expected between the recipient groups. It was
observed that with two exceptions, the numbers of
metastases present in the fresh recipients after 15 or
21 days were not significantly different. The two
exceptions were revealed by Wilcoxon-Mann-
Whitney tests but not t-tests, between 19- and 7-day
implants where significantly (0.05>P>0.01) more
metastases were found in the 7-day recipients after
15 days, and between 19- and 5-day implants after
21 days, significantly (0.05>P>0.01) more
metastases were found in the 19-day tumour
recipients.
Potential differences between the numbers of
metastases in the different groups were not
obscured by either different relative cancer cell
densities or different mitotic indices in the
implanted tumour fragments. The higher relative
densities in the 15-, 19- and 21-day implants
coupled with a high frequency of metastatic
phenotypes should have caused significantly higher
numbers of metastases than in the 5-, 7- and 9-day
tumour recipients. This was not observed. The
mitotic indices in the groups of "donor" tumours
were also not significantly different, with the
exception of samples taken from the juxtanecrotic
regions of the 21-day "donors". Thus, while these
experiments are compatible with the concept of a
random process in metastasis at cancer cell level,
they offer no support to the metastatic
"subpopulation" hypothesis.
In spite of a plethora of papers, there is little or
no direct evidence to support the hypothesis that
spontaneous metastases arise exclusively or
predominantly from pre-existing metastatic
subpopulations in the cancer generating them,
which consist of cancer cells with heritable (stable)
metastatic phenotypes. A corollary of this
hypothesis would be that the major cell populations
in metastases consists of cells of a metastatic
phenotype, whereas these would compose only a
comparatively minor subpopulation within the
original primary tumour. In contrast, it has been
proposed (Weiss, 1980b) that cells entering the
metastatic process do so from "transient metastatic
compartments." and that after allowance is made
for pathophysiologic differences between primary
and metastatic lesions, metastases are no more
likely to metastasize than their parent primary
tumour. The presnt studies support this proposal.
The issue is of considerable clinical importance
since metastasis of metastases is a key feature of the
natural history of cancer in Man (Sugarbaker et al.,
1971); many tumours first metastasize to
"generalizing" sites (e.g. lymphnodes, liver and
lungs), from which tertiary and subsequent
metastases arise (Bross & Blumenson, 1976).
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